Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Otago Medical School staff profiles

Dr Blair McLaren

PositionClinical Lecturer
DepartmentDepartment of Medicine (Dunedin)
QualificationsMB ChB(Otago) FRACP
Research summaryTreatment of breast cancer.
Teaching

Dr McLaren is a Clinical Lecturer employed by the Southern District Health Board. He is contracted to the Dunedin School of Medicine to teach medical students.

To contact Dr McLaren please use the email address on the right, or phone the Southern District Health Board on 64 3 474 0999.

ClinicalBreast cancer, lung cancer.

Publications

Jones, L. M., Stoner, L., Brown, C., Baldi, J. C., & McLaren, B. (2019). Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion. Breast Cancer. Advance online publication. doi: 10.1007/s12282-019-00975-2

Liu, L., Petrich, S., McLaren, B., Kelly, L., & Baxter, G. D. (2018). An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy: Study protocol for a randomized controlled feasibility study. Journal of Integrative Medicine, 16(2), 99-105. doi: 10.1016/j.joim.2017.12.011

Sharma, M., Tuaine, J., McLaren, B., Waters, D. L., Black, K., Jones, L. M., & McCormick, S. P. A. (2016). Chemotherapy agents alter plasma lipids in breast cancer patients and show differential effects on lipid metabolism genes in liver cells. PLoS ONE, 11(1), e0148049. doi: 10.1371/journal.pone.0148049

Harvey, V. J., Sharples, K. J., Isaacs, R. J., Jameson, M. B., Jeffery, G. M., McLaren, B. R., … Simpson, A. B., … Findlay, M. P. (2013). A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. Annals of Oncology, 24(7), 1828-1834. doi: 10.1093/annonc/mdt065

Jones, L. M., Stoner, L., Brown, C., Baldi, C., & McLaren, B. (2013). Cardiovascular disease among breast cancer survivors: The call for a clinical vascular health toolbox. Breast Cancer Research & Treatment, 142(3), 645-653. doi: 10.1007/s10549-013-2766-9

Journal - Research Article

Jones, L. M., Stoner, L., Brown, C., Baldi, J. C., & McLaren, B. (2019). Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion. Breast Cancer. Advance online publication. doi: 10.1007/s12282-019-00975-2

Sharma, M., Tuaine, J., McLaren, B., Waters, D. L., Black, K., Jones, L. M., & McCormick, S. P. A. (2016). Chemotherapy agents alter plasma lipids in breast cancer patients and show differential effects on lipid metabolism genes in liver cells. PLoS ONE, 11(1), e0148049. doi: 10.1371/journal.pone.0148049

Harvey, V. J., Sharples, K. J., Isaacs, R. J., Jameson, M. B., Jeffery, G. M., McLaren, B. R., … Simpson, A. B., … Findlay, M. P. (2013). A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. Annals of Oncology, 24(7), 1828-1834. doi: 10.1093/annonc/mdt065

Jones, L. M., Stoner, L., Brown, C., Baldi, C., & McLaren, B. (2013). Cardiovascular disease among breast cancer survivors: The call for a clinical vascular health toolbox. Breast Cancer Research & Treatment, 142(3), 645-653. doi: 10.1007/s10549-013-2766-9

^ Top of page

Journal - Research Other

Liu, L., Petrich, S., McLaren, B., Kelly, L., & Baxter, G. D. (2018). An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy: Study protocol for a randomized controlled feasibility study. Journal of Integrative Medicine, 16(2), 99-105. doi: 10.1016/j.joim.2017.12.011

Pattison, S. T., & McLaren, B. R. (2013). Triple negative breast cancer in a male-to-female transsexual [Brief communication]. Internal Medicine Journal, 43(2), 203-205. doi: 10.1111/imj.12047

More publications...